Cargando…

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)

Detalles Bibliográficos
Autores principales:	Lovillo, MS Camacho, Iglesias, E, Neth, O, Santa-María, V, Sánchez, A, Bernabeu, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194708/ http://dx.doi.org/10.1186/1546-0096-9-S1-P5

Ejemplares similares

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
por: Ugurlu, S, et al.
Publicado: (2015)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra
por: Celebi, Zeynep Kendi, et al.
Publicado: (2014)

Ulcerative Colitis and Familial Mediterranean Fever: Can Anakinra Treat Both?
por: Kaly, Lisa, et al.
Publicado: (2019)

Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy
por: Aiello, A, et al.
Publicado: (2023)

Clinical and genetic peculiarities of vasculitis associated with Familial Mediterranean fever in Armenian children
por: Amaryan, G, et al.
Publicado: (2015)

Association of Vasculitis and Familial Mediterranean Fever
por: Abbara, Salam, et al.
Publicado: (2019)

Vasculitis associated with familial Mediterranean fever: a study on 16 french adult cases
por: Abbara, S, et al.
Publicado: (2015)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever
por: Cakan, Mustafa, et al.
Publicado: (2019)

The IL-1 inhibitor Canakinumab for Familial Mediterranean Fever: the Greek experience in 12 patients
por: Laskari, K, et al.
Publicado: (2015)

Screening of free carnitine and acyl-carnitine status in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients
por: Vitale, A, et al.
Publicado: (2008)

The association of Familial Mediterranean Fever and cryptogenic cirrhosis
por: Baskin, E, et al.
Publicado: (2008)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Musculoskeletal complaints in patients with Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever associated diseases in children
por: Özçakar, ZB, et al.
Publicado: (2015)

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Quality of life in children with familial Mediterranean fever
por: Öztürk, Ö, et al.
Publicado: (2015)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Zytokin profiles in familial Mediterranean fever patients: IL-18 as a major cytokine and potential biomarker or target
por: Igney-Oertel, A, et al.
Publicado: (2015)

Vasculitis and long standing ankylosing spondylitis in a patient with familial Mediterranean fever
por: Taylan, Ali, et al.
Publicado: (2014)

Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
por: Roy, Noémi B A, et al.
Publicado: (2020)

IL-1 blockade in inherited fever syndromes - what have we learnt?
por: Lachmann, Helen J
Publicado: (2011)

Pulmonary hypertension in familial Mediterranean fever: consequence or coincidence?
por: Sargsyan, A, et al.
Publicado: (2015)

Challenging case of Familial Mediterranean Fever and its management
por: Al Hosani, A, et al.
Publicado: (2015)

IL‐1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis
por: Gorelik, M., et al.
Publicado: (2019)

Rapidly progressive glomerulonephritis in a child with Henoch-Schönlein Vasculitis and familial Mediterranean fever
por: Sozeri, Betul, et al.
Publicado: (2009)

Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus
por: Dein, Eric, et al.
Publicado: (2018)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Risk factors for subclinical inflammation in children with familial mediterranean fever
por: Soylu, Alper, et al.
Publicado: (2014)

Evidence based recommendations for genetic diagnosis of Familial Mediterranean Fever
por: Giancane, Gabriella, et al.
Publicado: (2014)

Familial Mediterranean Fever in childhood: a single center experience
por: Barut, K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pqh9prgodt5g1evcj56jkbjbdn